Henriette E Meyer Zu Schwabedissen (Henriette Meyer Zu Schwabedissen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 37

Top Topics

Clinical Practice

Lower Urinary Tract Symptoms

Top Venues

Clinical and translational science

The Journal of pharmacology and experimental therapeutics

Clinical pharmacology and therapeutics

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)
Céline K Stäuble, Markus L Lampert, Allemann Samuel, Henriette E Meyer Zu Schwabedissen
A Clinical Practice Perspective on the Evaluation of OATP1B1-associated Drug Interactions. Clinical pharmacology and therapeutics (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Jonny Kinzi, Janine Hussner, Isabell Seibert, Mirubagini Vythilingam, Celina Vonwyl, Clarisse Gherardi, Pascal Detampel, Oliver Schwardt, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Impact of OATP2B1 on pharmacokinetics of atorvastatin investigated in rSlco2b1 -knockout and SLCO2B1 -knockin rats. Drug metabolism and disposition: the biological fate of chemicals (2024)
Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)
Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Jonny Kinzi, Janine Hussner, Isabell Seibert, Mirubagini Vythilingam, Celina Vonwyl, Clarisse Gherardi, Pascal Detampel, Oliver Schwardt, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in rSlco2b1 -Knockout and SLCO2B1 -Knockin Rats. Drug metabolism and disposition: the biological fate of chemicals 52 (9) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in rats increases rCYP3A1 protein expression but not the metabolism of erlotinib to OSI-420 . The Journal of pharmacology and experimental therapeutics (2024)
Céline K Stäuble, Markus L Lampert, Allemann Samuel, Henriette E Meyer Zu Schwabedissen
A Clinical Practice Perspective on the Evaluation of OATP1B1-associated Drug Interactions. Clinical pharmacology and therapeutics 116 (1) (2024)
Kevin Kirchner, Linda Garvert, Katharina Wittfeld, Sabine Ameling, Robin Bülow, Henriette E Meyer Zu Schwabedissen, Matthias Nauck, Henry Völzke, Hans J Grabe, Sandra Van der Auwera
Deciphering the Effect of Different Genetic Variants on Hippocampal Subfield Volumes in the General Population. International journal of molecular sciences 24 (2) (2023)
Kevin Kirchner, Linda Garvert, Katharina Wittfeld, Sabine Ameling, Robin Bülow, Henriette E Meyer Zu Schwabedissen, Matthias Nauck, Henry Völzke, Hans J Grabe, Sandra Van der Auwera
Deciphering the Effect of Different Genetic Variants on Hippocampal Subfield Volumes in the General Population. International journal of molecular sciences 24 (2) (2023)
Florine M Wiss, Céline K Stäuble, Henriette E Meyer Zu Schwabedissen, Allemann Samuel, Markus L Lampert
Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy. Journal of personalized medicine 13 (5) (2023)
Jonny Kinzi, Markus Grube, Karin Brecht, Isabell Seibert, Werner Siegmund, Henriette E Meyer Zu Schwabedissen
Various effects of repeated rifampin dosing on coproporphyrin levels in humans. Clinical and translational science (2023)
Anna Bollinger, Chiara Jeiziner, Henriette E Meyer Zu Schwabedissen, Hersberger Kurt, Allemann Samuel, Céline K Stäuble
Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report. Pharmacogenomics (2023)
Anna Bollinger, Céline K Stäuble, Chiara Jeiziner, Florine M Wiss, Hersberger Kurt, Markus L Lampert, Henriette E Meyer Zu Schwabedissen, Allemann Samuel
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study. Pharmacogenomics and personalized medicine 16 (2023)
Kevin Kirchner, Linda Garvert, Katharina Wittfeld, Sabine Ameling, Robin Bülow, Henriette E Meyer Zu Schwabedissen, Matthias Nauck, Henry Völzke, Hans J Grabe, Sandra Van der Auwera
Deciphering the Effect of Different Genetic Variants on Hippocampal Subfield Volumes in the General Population. International journal of molecular sciences 24 (2) (2023)
Anima M Schäfer, Marta A Rysz, Julia Schädeli, Michelle Hübscher, Haleh Khosravi, Michelle Fehr, Isabell Seibert, Olivier Potterat, Martin Smieško, Henriette E Meyer Zu Schwabedissen
St. John's wort formulations induce rat CYP3A23-3A1 independent of their hyperforin content . Molecular pharmacology (2023)
Valerio Taggi, Mario Riera Romo, Micheline Piquette-Miller, Henriette E Meyer Zu Schwabedissen, Sibylle Neuhoff
Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta. Pharmaceutics 14 (7) (2022)
Céline K Stäuble, Chiara Jeiziner, Anna Bollinger, Florine M Wiss, Martin Hatzinger, Hersberger Kurt, Thomas Ihde, Markus L Lampert, Thorsten Mikoteit, Henriette E Meyer Zu Schwabedissen, Allemann Samuel
A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting. Pharmacy (Basel, Switzerland) 10 (4) (2022)
Romy Tilen, Paolo Paioni, Aljoscha N Goetschi, Roland Goers, Isabell Seibert, Daniel Müller, Julia A Bielicki, Christoph Berger, Stefanie D Krämer, Henriette E Meyer Zu Schwabedissen
Pharmacogenetic Analysis of Voriconazole Treatment in Children. Pharmaceutics 14 (6) (2022)
Kim L R Brouwer, Raymond Evers, Elizabeth Hayden, Shuiying Hu, Cindy Yanfei Li, Henriette E Meyer Zu Schwabedissen, Sibylle Neuhoff, Stefan Oswald, Micheline Piquette-Miller, Chitra Saran, Noora Sjöstedt, Jason A Sprowl, Simone H Stahl, Wei Yue
Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clinical pharmacology and therapeutics 112 (3) (2022)
Nina L Wittwer, Christoph R Meier, Carola A Huber, Henriette E Meyer Zu Schwabedissen, Allemann Samuel, Cornelia Schneider
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database. Pharmacogenomics and personalized medicine 15 (2022)
Paolo Paioni, Vera F Jäggi, Romy Tilen, Michelle Seiler, Philipp Baumann, Dominic S Bräm, Carole Jetzer, Robin T U Haid, Aljoscha Noël Goetschi, Roland Goers, Daniel Müller, Diana Coman Schmid, Henriette E Meyer Zu Schwabedissen, Bernd Rinn, Christoph Berger, Stefanie D Krämer
Gentamicin Population Pharmacokinetics in Pediatric Patients-A Prospective Study with Data Analysis Using the saemix Package in R. Pharmaceutics 13 (10) (2021)
Roland Goers, Diana Coman Schmid, Vera F Jäggi, Paolo Paioni, Michal J Okoniewski, Althea Parker, Beat Bangerter, Sofia Georgakopoulou, Thierry Sengstag, Julia Bielicki, Romy Tilen, Swen Vermeul, Stefanie D Krämer, Christoph Berger, Bernd Rinn, Henriette E Meyer Zu Schwabedissen
SwissPKcdw - A clinical data warehouse for the optimization of pediatric dosing regimens. CPT: pharmacometrics & systems pharmacology (2021)
Céline K Stäuble, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Hersberger Kurt, Henriette E Meyer Zu Schwabedissen
Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report. Life (Basel, Switzerland) 11 (7) (2021)
Fabio Bachmann, Henriette E Meyer Zu Schwabedissen, Urs Duthaler, Stephan Krähenbühl
Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. British journal of clinical pharmacology (2021)
Céline K Stäuble, Chiara Jeiziner, Hersberger Kurt, Henriette E Meyer Zu Schwabedissen, Markus L Lampert
Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept. Pharmacy (Basel, Switzerland) 9 (3) (2021)
Anima M Schäfer, Henriette E Meyer Zu Schwabedissen, Sandra Bien-Möller, Andrea Hubeny, Silke Vogelgesang, Stefan Oswald, Markus Grube
OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists. Molecular pharmaceutics 17 (6) (2020)
Simon Nicolussi, Juergen Drewe, Veronika Butterweck, Henriette E Meyer Zu Schwabedissen
Clinical relevance of St. John's wort drug interactions revisited. British journal of pharmacology 177 (6) (2020)
Daniel Ehrsam, Sandro Sieber, Mouhssin Oufir, Fabiola Porta, Matthias Hamburger, Joerg Huwyler, Henriette E Meyer Zu Schwabedissen
Design, Synthesis, and Characterization of a Paclitaxel Formulation Activated by Extracellular MMP9. Bioconjugate chemistry 31 (3) (2020)
Céline K Stäuble, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Hersberger Kurt, Henriette E Meyer Zu Schwabedissen
Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a case report. Pharmacogenomics 21 (16) (2020)
Dominik Witzigmann, Philipp Uhl, Sandro Sieber, Christina Kaufman, Tomaz Einfalt, Katrin Schöneweis, Philip Grossen, Jonas Buck, Yi Ni, Susanne H Schenk, Janine Hussner, Henriette E Meyer Zu Schwabedissen, Gabriela Québatte, Walter Mier, Stephan Urban, Joerg Huwyler
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide. eLife 8 (2019)
Patrick Vizeli, Henriette E Meyer Zu Schwabedissen, Matthias E Liechti
Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects. ACS chemical neuroscience 10 (7) (2019)
Anima M Schäfer, Thomas Bock, Henriette E Meyer Zu Schwabedissen
Establishment and Validation of Competitive Counterflow as a Method To Detect Substrates of the Organic Anion Transporting Polypeptide 2B1. Molecular pharmaceutics 15 (12) (2018)
Fabiola Porta, Daniel Ehrsam, Claudia Lengerke, Henriette E Meyer Zu Schwabedissen
Synthesis and Characterization of PDMS-PMOXA-Based Polymersomes Sensitive to MMP-9 for Application in Breast Cancer. Molecular pharmaceutics 15 (11) (2018)